An update on the pharmacotherapy of excessive daytime sleepiness and cataplexy.
Mignot
Emmanuel
E
D000818:Animals; D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001559:Benzhydryl Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D002385:Cataplexy / Q000188:drug therapy*; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006970:Disorders of Excessive Somnolence / Q000188:drug therapy*; D004285:Dogs; D006801:Humans; D000077408:Modafinil; D009290:Narcolepsy / Q000188:drug therapy*; D012978:Sodium Oxybate / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
D000928:Antidepressive Agents; D001559:Benzhydryl Compounds; D000697:Central Nervous System Stimulants; D012978:Sodium Oxybate; D000077408:Modafinil